A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's deadliest infectious disease.

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world's ...

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse than Covid,” says global health expert Seth Berkley.

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

Dr. Steven J. Hatfill, a biosecurity expert hired by HHS Secretary Robert F. Kennedy Jr., has been fired. He was a skeptic of ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...